Traws Pharma, Inc. (($TRAW)) announced an update on their ongoing clinical study. Study Overview: Traws Pharma, Inc. is conducting a Phase 1 ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has launched a Phase 1 clinical study titled ‘AN ...
Pharmacokinetics in neonates examines the unique processes of absorption, distribution, metabolism, and excretion that govern drug behaviour in this vulnerable population. Owing to rapid physiological ...
The concurrent use of herbal medicines alongside conventional pharmaceuticals has markedly increased, giving rise to significant herb-drug interactions that may alter drug efficacy and safety. These ...
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors From September 7, 2020, to February 27, ...
Credit: Getty Images In a 3-part series, authors discussed the neurocognitive impact of long-term medications in patients with CKD. Patients with CKD may be more susceptible to cognitive adverse drug ...
Positive Results from Clinical Pharmacokinetic Study for the Eosinophilic Esophagitis Specific Formulation with the Drug Candidate AQ280Aqilion today announces positive results from the ARIA-2 ...
Obesity affects the way drugs behave in the body. Yet, our regulatory systems ignore this fact entirely. At a recent virtual workshop on drug safety and efficacy in people with obesity, Food and Drug ...
The company is dropping its social anxiety disorder program but will still test the molecule in post-traumatic stress ...
Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...
Delix Therapeutics, a clinical‑stage neuroscience company pioneering a new class of treatments known as neuroplastogens, today announced positive results from its Phase Ib clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results